PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN

• N. Pemmaraju,
• G. Martinelli,
• E. Todisco,
• C. Tarella,
• P. Montesinos,
• A. A. Lane,
• H. P. Erba,
• K. L. Sweet,
• R. B. Walter,
• E. Deconinck,
• E. S. Wang,
• A. Aribi,
• M. L. Ulrikson,
• M. Y. Levy,
• D. Lebon,
• G. Marconi,
• D. J. DeAngelo,
• D. Rizzieri,
• M. Konopleva,
• C. M. Sloss,
• J. Wang,
• K. A. Malcolm,
• P. A. Zweidler-McKay,
• N. G. Daver

Affiliations

N. Pemmaraju

1 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, United States of America

G. Martinelli

2 Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “L. e A. Seràgnoli”, Bologna

E. Todisco

3 Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy

C. Tarella

3 Division of Onco-Hematology, European Institute of Oncology IRCCS, Milano, Italy

P. Montesinos

4 Hospital Universitari i Politècnic La Fe, Valencia, Spain

A. A. Lane

5 Department of Medical Oncology, Dana-Farber/Boston Children’s Cancer and Blood Disorders Ctr, Boston

H. P. Erba

6 Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham

K. L. Sweet

7 Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa

R. B. Walter

8 Fred Hutchinson Cancer Research Center, Seattle, United States of America

E. Deconinck

9 Clinical Hematology, Besançon University Hospital, Besançon, France

E. S. Wang

10 Roswell Park Comprehensive Cancer Center, Buffalo

A. Aribi

11 Gehr Family Center for Leukemia Research, City of Hope, Duarte

M. L. Ulrikson

12 Banner Health MD Anderson Cancer Center, Gilbert

M. Y. Levy

13 Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, United States of America

D. Lebon

14 Department of Clinical Hematology and Cellular Therapy, Amiens University Medical Center, Amiens, France

G. Marconi

15 Istituto Seragnoli, Bologna, Italy

D. J. DeAngelo

16 Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston

D. Rizzieri

17 Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham

M. Konopleva

18 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

C. M. Sloss

19 ImmunoGen, Inc., Waltham, United States of America

J. Wang

19 ImmunoGen, Inc., Waltham, United States of America

K. A. Malcolm

19 ImmunoGen, Inc., Waltham, United States of America

P. A. Zweidler-McKay

19 ImmunoGen, Inc., Waltham, United States of America

N. G. Daver

18 Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston